Genetic induction of anti-viral immune response and genetic vaccine for filovirus
US6200959A · kind A · utility
34Cited by
5References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 4, 1996 |
| Grant date | Mar 13, 2001 |
| Priority date | — |
| Expiry date | Dec 4, 2016 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2760/14234
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An approach to genetic vaccine methodology is described. A genetic construction encoding antigenic determinants of a filovirus is transfected into cells of the vaccinated individuals using a particle acceleration protocol so as to express the viral antigens in healthy cells to produce an immune response to those antigens.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.